Tags: REGN

Brief Overview Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), from Healthcare sector has been performing well. Regeneron Pharmaceuticals, Inc. reported a price of 510.1 today, indicating a change of -3.12%. Regeneron Pharmaceuticals, Inc. has a market capitalization of 57.13 B, with a return on assets (ROA) of 13.80% and an earnings per share (EPS) of 8.31 for the…

Brief Overview Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), from Healthcare sector has been performing well. Regeneron Pharmaceuticals, Inc. reported a price of 522.02 today, indicating a change of 5.39%. Regeneron Pharmaceuticals, Inc. has a market capitalization of 56.64 B, with a return on assets (ROA) of 13.80% and an earnings per share (EPS) of 8.31 for the…

Brief Overview Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), from Healthcare sector has been performing well. Regeneron Pharmaceuticals, Inc. reported a price of 495.33 today, indicating a change of 5.02%. Regeneron Pharmaceuticals, Inc. has a market capitalization of 53.75 B, with a return on assets (ROA) of 13.80% and an earnings per share (EPS) of 8.31 for the…

With its market value over its outstanding shares, Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Biotechnology has a market capitalization valued at Biotechnology. As the outstanding stock of Regeneron Pharmaceuticals, Inc. NASDAQ:REGN Biotechnology is bought and sold in the stock market, the current market cap indicates the existing public opinion of the net worth of Regeneron Pharmaceuticals, Inc. REGN Biotechnology. The existing figure surely determines…

Brief Overview Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), from Healthcare sector has been performing well. Regeneron Pharmaceuticals, Inc. reported a price of 476.84 today, indicating a change of 0.67%. Regeneron Pharmaceuticals, Inc. has a market capitalization of 50.28 B, with a return on assets (ROA) of 13.80% and an earnings per share (EPS) of 8.31 for the…

Outlined as the total market value of all unsettled shares of the company, the current market cap for the Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Biotechnology is valued at 50.21 B. The dominant statistics will authorize the investment community to govern the size of Regeneron Pharmaceuticals, Inc. compared to the sales or total assets figures. Consequently, investors will be able…

Summary of Regeneron Pharmaceuticals, Inc. (REGN) | Monday May 8, 2017 Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), from Healthcare sector has been on the upside of the performance spectrum. Regeneron Pharmaceuticals, Inc. stated a price of 426.41 today, indicating a positive change of -0.60%. Regeneron Pharmaceuticals, Inc. is operating with a market capitalization of 42.73B, with a return on assets (ROA)…

Today’s High Market Cap Stock of the day is Regeneron Pharmaceuticals, Inc., (NASDAQ: REGN), with a large market cap of 43.57B. Regeneron Pharmaceuticals, Inc. is in the industry Biotechnology and sector Healthcare. The home country is USA, and was first put on the stock market on the IPO date, 04/02/1991. Regeneron Pharmaceuticals, Inc.’s price right now…

THE QUANTITATIVE RELATIONSHIPS Regeneron Pharmaceuticals, Inc. (REGN), started its day with an opening price of 401.58 as the company saw a change of -0.11%. The Average Volume of the business is currently 925.5 with a P/E (price to earnings) ratio of 52.15 , while Forward P/E ratio is 26.24. The price to earnings ratio specifies…

Overview: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), from Healthcare sector has been doing well recently. Regeneron Pharmaceuticals, Inc. has been operating with a total market capitalizations of 39.74 B and has reported a price of 396.17 today, highlighting a positive change of 1.98%. The average volume stands at 920.58 for Regeneron Pharmaceuticals, Inc.. Performance: The performance week…